GleamWall
中文EN

BCRX BIOCRYST PHARMACEUTICALS INC

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 882796 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY60.3%
TTM net income YoY-3,996.8%
TTM EPS YoY-2,460.0%
Revenue 3-yr CAGR44.7%
Net income 3-yr CAGR—

Margins

Gross margin97.9%
Operating margin-30.1%
Net margin-37.4%
FCF margin38.0%
EBITDA margin-29.9%

Returns

ROE—
ROA-69.3%
ROIC (approx.)—
Asset turnover1.85x

Leverage & solvency

Liabilities / assets167.2%
Debt / equity—
Current ratio2.71x
Interest coverage-3.77x

Cash quality & payout

Operating cash flow / net income-1.02x
Accruals ratio-140.2%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$874.84M$450.71M
Cost of revenue$19.07M$12.27M
Gross profit$855.76M$438.44M
R&D expense$166.13M$174.64M
SG&A expense$348.65M$266.35M
Operating income$340.99M-$2.54M
Interest expense$78.87M$98.52M
Pretax income$267.39M-$86.95M
Income tax$3.53M$1.93M
Net income$263.86M-$88.88M
EBITDA$342.38M-$1.30M
EPS (basic)1.26-0.43
EPS (diluted)1.21-0.43
Weighted avg. shares (diluted)218.58M206.70M
Balance sheet
Cash & equivalents$89.74M$106.32M
Short-term investments$185.01M$216.14M
Receivables$106.82M$79.07M
Inventory$5.40M$8.09M
Current assets$404.35M$421.97M
PP&E, net$8.78M$7.78M
Total assets$514.16M$490.42M
Current liabilities$196.07M$160.38M
Long-term debt$0$314.87M
Total debt$0$314.87M
Total liabilities$633.31M$966.35M
Shareholders' equity-$119.15M-$475.93M
Net debt-$89.74M$208.55M
Shares outstanding213.06M208.54M
Cash flow statement
Operating cash flow$347.37M-$52.02M
Capital expenditure$2.47M$1.12M
Free cash flow$344.90M-$53.14M
Investing cash flow-$13.69M$52.59M
Financing cash flow-$349.93M-$5.76M
Depreciation & amortization$1.39M$1.25M
Stock-based compensation$85.07M$65.41M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.